[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355028-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355028-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","platelet-indices-as-prognostic-biomarkers-in-lung-cancer-a-meta-analysis-and-mendelian-randomization-study","Platelet indices as prognostic biomarkers in lung cancer - A meta-analysis and Mendelian randomization study","","Platelet indices (PIs) including platelet count (PC), plateletcrit (PCT), mean platelet volume, and platelet distribution width are commonly measured, yet their prognostic thresholds and causal contribution to lung cancer outcomes remain unclear. A systematic review and meta-analysis of studies through December 2024 pooled hazard ratios, modeled nonlinear dose–response relationships, and applied two-sample Mendelian randomization with sensitivity analyses to assess causality and population differences.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/platelet-indices-as-prognostic-biomarkers-in-lung-cancer-a-meta-analysis-and-mendelian-randomization-study/355028/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/platelet-indices-as-prognostic-biomarkers-in-lung-cancer-a-meta-analysis-and-mendelian-randomization-study/355028.png","ImageObject",300,407,{"name":42,"@type":43},"Hazel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which platelet indices were evaluated and why?","Question",{"text":63,"@type":64},"The study assessed platelet indices including platelet count (PC), plateletcrit (PCT), mean platelet volume, and platelet distribution width (PDW) because they are routinely measured, but their prognostic value and causality in lung cancer were not fully established.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were prognostic effects and dose–response thresholds determined?",{"text":68,"@type":64},"Hazard ratios were pooled using random-effects models, and dose–response thresholds were identified with restricted cubic splines and generalized least squares to reveal nonlinear relationships.",{"name":70,"@type":61,"acceptedAnswer":71},"What did Mendelian randomization show about causality?",{"text":72,"@type":64},"Two-sample Mendelian randomization indicated population-specific causal effects, with PC increasing lung cancer risk in East Asians and both PC and PCT increasing risks in Europeans, alongside sensitivity analyses to support robustness.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355028,1790304967,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","®  \nSystematic Review and Meta-Analysis   \nPlatelet indices as prognostic biomarkers in lung cancer  \nA meta-analysis and Mendelian randomization study  \nMengqi Yuan, MDa , Hongyang Chen, MDb ,c , Zishen Liu, MDa , Yingying Zheng, MDa , Shiyu Liu, MMa , Ganlin Zhang, MDa , Guowang Yang, MDa ,*  \n\n| Abstract\u003Cbr>Background: Platelet indices (PIs)– including platelet count (PC), plateletcrit (PCT), mean platelet volume, and platelet distribution width (PDW)– are routinely assessed in clinical practice. Although observational studies have reported associations between PIs and lung cancer outcomes, the dose–response relationship and causality remain unestablished. This study aims to determine prognostic thresholds of PIs and elucidate their causal roles in lung cancer.\u003Cbr>Methods: We systematically reviewed PubMed, Medline, and Web of Science (through December 2024) for studies on PIs and lung cancer prognosis. Hazard ratios (HRs) were pooled via random-effects models. Dose–response thresholds were identified using restricted cubic splines and generalized least squares. Two-sample Mendelian randomization (MR) analyses with inverse variance weighting assessed causality, complemented by sensitivity analyses (MR-Egger, weighted median) .\u003Cbr>Results: In the meta-analysis of 62 studies (N = 38,562 patients), elevated PC (HR = 1.016, 95% CI: 1.009 to 1.024) and PCT (HR = 1.704, 95% CI: 1.040–2.790) independently predicted poorer overall survival. A nonlinear dose–response relationship revealed that each 109/L increase in PC conferred a 4 .2% higher risk of adverse prognosis in non-small cell lung cancer (HR = 1.042, 95% CI: 1.029 to 1.056), with a critical threshold at 177.5 × 109/mL. MR analyses demonstrated population-specific causality: a 1-SD increase in PC elevated lung cancer risk by 33% in East Asians (OR = 1.33, P \u003C .001), while in Europeans, equivalent increments in PC and PCT increased small cell lung cancer (SCLC) risk by 17%(OR = 1. 17, P = .01) and 19%(OR = 1. 19, P \u003C .001), respectively. Additionally, higher PDW was causally linked to a 6% increased lung cancer risk (OR = 1.06, P = .02) . Conclusion: This first study integrating dose–response meta-analysis and MR evidence identifies PC and PCT as robust prognostic biomarkers for lung cancer, with population-specific causal effects. The identified PC threshold (177 .5 × 109/mL) provides a clinically actionable tool for NSCLC risk stratification, highlighting the translational potential of routine PIs monitoring in oncology practice.\u003Cbr>Abbreviations: HR = hazard ratio, MPV = mean platelet volume, MR = Mendelian randomization, NOS = Newcastle–Ottawa scale, NSCLC = non-small cell lung cancer, PC = platelet count, PCT = plateletcrit, PDW = platelet distribution width, PI = platelet indice, SCLC = small cell lung cancer. |\n| --- |\n| Keywords: biomarkers, lung cancer, Mendelian randomization, meta-analysis, platelet |\n\n1. Introduction  \nLung cancer, histologically categorized into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), remains a predominant contributor to global cancer mortality.[1] As of 2021, it accounted for an estimated 2.28 million (95% UI:  \n2.06–2.51) new cases and 2.02 million (1 .82–2.22) deaths annually worldwide. [2] Recent advances in precision oncology have identified molecular biomarkers – such as ALK, EGFR, BRAF, ROS1 mutations, and PD-1/PD-L1 expression – as critical predictors of prognosis and therapeutic response, guiding targeted therapy selection. [3–6] However, the widespread  \nMY, HC, and ZL contributed to this article equally.  \nThis work was supported by the National Natural Science Foundation of China (Grant No: NSFC 82174453).  \nThe authors have no conflicts of interest to disclose.  \nThe datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.  \nSupplemental Digital Content is available for this article.  \na Department of Oncology, Beijing Hospita","cbCaid8UbIA0y0vR","https://ap.wps.com/l/cbCaid8UbIA0y0vR","pdf",2149305,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n## Abbreviations\n# Introduction\n## Epidemiology and current biomarkers\n## Rationale for platelet testing","[{\"question\":\"Which platelet indices were evaluated and why?\",\"answer\":\"The study assessed platelet indices including platelet count (PC), plateletcrit (PCT), mean platelet volume, and platelet distribution width (PDW) because they are routinely measured, but their prognostic value and causality in lung cancer were not fully established.\"},{\"question\":\"How were prognostic effects and dose–response thresholds determined?\",\"answer\":\"Hazard ratios were pooled using random-effects models, and dose–response thresholds were identified with restricted cubic splines and generalized least squares to reveal nonlinear relationships.\"},{\"question\":\"What did Mendelian randomization show about causality?\",\"answer\":\"Two-sample Mendelian randomization indicated population-specific causal effects, with PC increasing lung cancer risk in East Asians and both PC and PCT increasing risks in Europeans, alongside sensitivity analyses to support robustness.\"}]","Platelet indices as prognostic biomarkers in lung cancer - A meta-analysis and Mendelian randomization study | PDF",1790115489,38,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0adce1f08ce0084fec4a13ab8eebf390.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d34a42e54bff3b0cb35e12e78fb3dc95.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a9c86f0f4693c06531f4fb2de58ae5a.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3810b849c29e87c40a008f421eae392.webp",980,1306]